RAFAEL PENUNURI: Open Payments
NPI 1831270362 · NEWPORT BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$733 in 28 payments from 10 companies in 2025. Trend: 2023 $389 · 2024 $735 · 2025 $733
Food & beverage: $733
| Company | Payments | Amount |
|---|---|---|
| Braeburn Inc. | 9 | $289 |
| Indivior Inc. | 4 | $115 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $95 |
| Kowa Pharmaceuticals America, Inc. | 3 | $56 |
| Amgen Inc. | 2 | $50 |
| ABBVIE INC. | 2 | $42 |
| SANOFI-AVENTIS U.S. LLC | 1 | $28 |
| PFIZER INC. | 1 | $20 |
| Gilead Sciences, Inc. | 1 | $19 |
| TOLMAR, INC. | 1 | $18 |
Products named: BRIXADI, SUBLOCADE, CAPLYTA, ZORYVE, OTEZLA, VRAYLAR, TZIELD, ELIQUIS.
Industry payments across CA — which companies pay providers there.
